Tuberculosis in the United Kingdom and Republic of Ireland

S S S Teo1, A Riordan, M Alfaham

  • 1University of London, London, UK.

Insights

Pediatric tuberculosis cases in the UK and Ireland were reviewed. Many children lacked specialist care, highlighting the need for managed clinical networks to improve tuberculosis management in children.

Area of Science:

  • Pediatric infectious diseases
  • Public health surveillance
  • Clinical microbiology

Background:

  • Tuberculosis (TB) remains a significant global health concern, with pediatric cases presenting unique diagnostic and management challenges.
  • Effective surveillance and management strategies are crucial for controlling the spread of TB in vulnerable populations.
  • Understanding the epidemiology and clinical characteristics of pediatric TB is essential for optimizing healthcare delivery.

Purpose of the Study:

  • To delineate the clinical spectrum, diagnostic approaches, and treatment outcomes for pediatric tuberculosis in the United Kingdom and Republic of Ireland.
  • To assess the current management practices and identify areas for improvement in pediatric TB care.
  • To evaluate the impact of healthcare provider experience and specialized care on patient outcomes.

Main Methods:

  • A prospective surveillance study was conducted via the British Paediatric Surveillance Unit from December 2003 to January 2005.
  • Culture-confirmed and clinically diagnosed pediatric tuberculosis cases were reported.
  • Data collected included clinical presentation, diagnostic investigations, treatment, and outcomes.

Main Results:

  • 385 pediatric TB cases were reported, with pulmonary involvement in 40%.
  • Over half of cases presented clinically, with a probable source case identified in 36% of these.
  • Diagnostic challenges were noted, with only 26% of cultures yielding positive results; drug resistance was rare (0.4%).
  • Suboptimal management was observed, including disparities in quadruple drug therapy for non-white children (44% did not receive it) and limited involvement of pediatric subspecialists (57%).
  • Many reporting centers (83%) and respondents (75%) saw fewer than five cases, indicating limited experience.

Conclusions:

  • The study highlights that many pediatricians and centers encounter few tuberculosis cases, potentially impacting adherence to national guidelines.
  • Managed clinical networks for pediatric tuberculosis are recommended to standardize and enhance patient care.
  • Improved coordination and specialized input are necessary to optimize the management of children with tuberculosis.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...